Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial - Top-Institutions - MDSpire

Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial

  • By

  • Louis J. Aronne

  • Deborah B. Horn

  • Carel W. le Roux

  • Ariana M. Chao

  • Wayne Ho

  • Bruno Halpern

  • Ryan Griffin

  • Cathy Xie

  • Elisa Gomez Valderas

  • Clare J. Lee

  • Anderson Ribeiro

  • David M. Hyman

  • Leonard Glass

  • Neena Xavier

  • May 13, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    NewYork-Presbyterian Hospital–Columbia and Cornell (Weill Cornell Medicine)
    NewYork-Presbyterian Hospital–Columbia and Cornell (Weill Cornell Medicine)

    New York, NY

    Key Differentiators

    • Endocrinology
    • Diabetes
    • Metabolism

  • #2

    Brigham and Women’s Hospital (Harvard Medical School) and Joslin Diabetes Center
    Brigham and Women’s Hospital (Harvard Medical School) and Joslin Diabetes Center

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Diabetes

Original Source(s)

Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial

  • by Louis J. Aronne, Deborah B. Horn, Carel W. le Roux, Ariana M. Chao, Wayne Ho, Bruno Halpern, Ryan Griffin, Cathy Xie, Elisa Gomez Valderas, Clare J. Lee, Anderson Ribeiro, David M. Hyman, Leonard Glass, Neena Xavier

  • May 13, 2026

Related Content

Side Effects: They Googled It

Patients are mining Reddit and TikTok for symptom intel while you're not — and a small study calls it epistemic injustice. Different knowledge, mutually unrecognized. Maybe ask where they've been reading before you wave it off as anecdote.

Impact of body mass index on outcomes of cardiac rehabilitation: a systematic review and meta-analysis

A temporally Anchored Retrieval-Augmented Generation Framework for Metabolic and Bariatric Surgery Patient Education: An IFSO Artificial Intelligence Task Force Multinational Validation Study